日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform

基于机器学习的多发性骨髓瘤风险分层策略:来自 EMN-HARMONY 联盟平台的启示

Mosquera Orgueira, Adrian; Gonzalez Perez, Marta Sonia; D'Agostino, Mattia; Cairns, David A; Larocca, Alessandra; Palacios, Juan José Lahuerta; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Pérez Míguez, Carlos; Rojas Martínez, Javier Alberto; Mai, Elias K; Crucitti, Davide; Salwender, Hans; Dall'Olio, Daniele; Castellani, Gastone; Piñeiro Fiel, Manuel; Bringhen, Sara; Zweegman, Sonja; Cavo, Michele; Iqbal, Sofía; Hernandez Rivas, Jesus Maria; Bruno, Benedetto; Cook, Gordon; Kaiser, Martin F; Goldschmidt, Hartmut; Van De Donk, Niels W C J; Jackson, Graham; San-Miguel, Jesús F; Boccadoro, Mario; Mateos, Maria-Victoria; Sonneveld, Pieter

Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trial

随机临床试验中的适应性设计:HOVON87/NMSG18 多发性骨髓瘤试验的重新分析

Seefat, Maarten R; van der Maas, Niek G; Nasserinejad, Kazem; van der Holt, Bronno; Waage, Anders; Mellqvist, Ulf-Henrik; Vangsted, Annette Juul; Smit, Anna J T; Smits, Febe; Ypma, Paula F; van de Donk, Niels W C J; Blommestein, Hedwig M; Cornelissen, Jan J; Cucchi, David G J; Zweegman, Sonja; Versluis, Jurjen

T cell phenotype and clonality changes in myeloma patients with short overall survival

多发性骨髓瘤患者总生存期短时,T细胞表型和克隆性发生变化

Behsen, Alenka Djarmila; Vandsemb, Esten Nymoen; Slørdahl, Tobias Schmidt; Dybkær, Karen; Jakobsen, Maja Zimmer; Kashif, Muhammad; Lund, Johan; Luong, Vincent; Olsnes, Astrid Marta; Waage, Anders; Sponaas, Anne Marit; Misund, Kristine

Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group

根据年龄划分的多发性骨髓瘤患者的细胞遗传学异常:北欧骨髓瘤研究组的一项真实世界研究

Thorsteinsdóttir, Sigrún; Lemonakis, Konstantinos; Slørdahl, Tobias S; Rögnvaldsson, Sæmundur; Richardson, Anna Karen; Hermansen, Emil; Thorsen, Jonathan; Schjesvold, Fredrik; Moore, Kari Lenita Falck; Szabo, Agoston Gyula; Andersen, Mette K; Waage, Anders; Blimark, Cecilie Hveding; Vangsted, Annette

Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone

羟氯喹、卡非佐米和地塞米松联合抑制蛋白酶体和自噬治疗复发/难治性多发性骨髓瘤的I期临床试验

Slørdahl, Tobias S; Askeland, Frida Bugge; Hanssen, Margrete Sofie Sætre; Hov, Håkon; Sundt-Hansen, Stine Marie; Lindahl, Sofia; Vethe, Nils Tore; Hjorth-Hansen, Henrik; Fenstad, Mona H; Waage, Anders; Hjertner, Øyvind; Schjesvold, Fredrik; Sundan, Anders

In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease

在多发性骨髓瘤中,每月使用唑来膦酸治疗超过两年可提供持续保护,防止进行性骨病。

Lund, Thomas; Gundesen, Michael Tveden; Juul Vangsted, Annette; Helleberg, Carsten; Haukås, Einar; Silkjær, Trine; Asmussen, Jon Thor; Manuela Teodorescu, Elena; Amdi Jensen, Bo; Schmidt Slørdahl, Tobias; Nahi, Hareth; Waage, Anders; Abildgaard, Niels; Schjesvold, Fredrik

A patient with minimal myeloma treatment who survived for 20 years

一名接受极少骨髓瘤治疗的患者存活了20年

Behsen, Alenka Djarmila; Vandsemb, Esten Nymoen; Slørdahl, Tobias Schmidt; Hjorth-Hansen, Henrik; Quist-Paulsen, Petter; Misund, Kristine; Sponaas, Anne-Marit; Waage, Anders

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

伊沙佐米、来那度胺和地塞米松(IRD)联合细胞遗传学风险维持治疗在适合移植的多发性骨髓瘤患者中的应用:北欧骨髓瘤研究组开展的一项II期多中心研究

Partanen, Anu; Waage, Anders; Peceliunas, Valdas; Schjesvold, Fredrik; Anttila, Pekka; Säily, Marjaana; Uttervall, Katarina; Putkonen, Mervi; Carlson, Kristina; Haukas, Einar; Sankelo, Marja; Szatkowski, Damian; Hansson, Markus; Marttila, Anu; Svensson, Ronald; Axelsson, Per; Lauri, Birgitta; Mikkola, Maija; Karlsson, Conny; Abelsson, Johanna; Ahlstrand, Erik; Sikiö, Anu; Klimkowska, Monika; Matuzeviciene, Reda; Fenstad, Mona Hoysaeter; Ilveskero, Sorella; Pelliniemi, Tarja-Terttu; Nahi, Hareth; Silvennoinen, Raija

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

对于不适合移植的新诊断多发性骨髓瘤患者,采用伊沙佐米-沙利度胺-地塞米松诱导治疗,随后进行伊沙佐米或安慰剂维持治疗:HOVON-126/NMSG 21.13 研究的长期结果

Groen, Kazimierz; Schjesvold, Fredrik H; van der Holt, Bronno; Levin, Mark-David; Seefat, Maarten R; Hansson, Markus; Leys, Maria B L; Regelink, Josien C; Waage, Anders; Szatkowski, Damian; Axelsson, Per; Hieu Do, Trung; Svirskaite, Asta; van der Spek, Ellen; Haukas, Einar; Knut-Bojanowska, Dorota; Ypma, Paula F; Blimark, Cecilie H; Mellqvist, Ulf-Henrik; van de Donk, Niels W C J; Sonneveld, Pieter; Klostergaard, Anja; Vangsted, Annette J; Abildgaard, Niels; Zweegman, Sonja

Potential value of pre-planned imaging of bone disease in multiple myeloma

预先计划的骨骼疾病影像检查在多发性骨髓瘤中的潜在价值

Gundesen, Michael T; Asmussen, Jon Thor; Schjesvold, Fredrik; Vangsted, Annette Juul; Helleberg, Carsten; Haukås, Einar; Silkjær, Trine; Teodorescu, Elena Manuela; Jensen, Bo Amdi; Slørdahl, Tobias S; Nahi, Hareth; Waage, Anders; Abildgaard, Niels; Lund, Thomas